Northern Trust Corp Bio Affinity Technologies, Inc. Transaction History
Northern Trust Corp
- $658 Billion
- Q1 2025
A detailed history of Northern Trust Corp transactions in Bio Affinity Technologies, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 13,662 shares of BIAF stock, worth $4,645. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,662
Previous 13,662
-0.0%
Holding current value
$4,645
Previous $12,000
75.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding BIAF
# of Institutions
18Shares Held
512KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA177KShares$60,1440.0% of portfolio
-
Geode Capital Management, LLC Boston, MA119KShares$40,3540.0% of portfolio
-
Sheaff Brock Investment Advisors, LLC53.7KShares$18,2690.0% of portfolio
-
Captrust Financial Advisors Raleigh, NC27.9KShares$9,4800.0% of portfolio
-
Warberg Asset Management LLC Winnetka, IL22.5KShares$7,6500.05% of portfolio
About bioAffinity Technologies, Inc.
- Ticker BIAF
- Exchange
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 2,727,580
- Market Cap $927K
- Description
- bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is b...